EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 0.0108
March 31, 2026 -0.3935
December 31, 2025 4.652
September 30, 2025 0.3355
June 30, 2025 -0.1217
March 31, 2025 0.0987
December 31, 2024 1.145
September 30, 2024 0.6038
June 30, 2024 0.322
March 31, 2024 -0.3378
December 31, 2023 0.4882
September 30, 2023 -0.2908
June 30, 2023 -0.4089
March 31, 2023 -0.5302
December 31, 2022 0.1043
September 30, 2022 -0.5968
June 30, 2022 -0.5251
March 31, 2022 -0.6067
December 31, 2021 -0.0874
September 30, 2021 -0.379
June 30, 2021 -0.4806
Date Value
March 31, 2021 -0.5974
December 31, 2020 -0.2773
September 30, 2020 -0.387
June 30, 2020 -0.8783
March 31, 2020 -0.6722
December 31, 2019 -0.3773
September 30, 2019 -0.3445
June 30, 2019 -0.3221
March 31, 2019 -0.3526
December 31, 2018 -0.2189
September 30, 2018 -0.2197
June 30, 2018 -0.4324
March 31, 2018 -0.3052
December 31, 2017 -0.2001
September 30, 2017 -0.1892
June 30, 2017 -0.2238
March 31, 2017 -0.2108
December 31, 2016 -0.2084
September 30, 2016 -0.1818
June 30, 2016 -0.238
March 31, 2016 -0.2436

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. 1.103
Intuitive Surgical, Inc. 2.290
Stryker Corp. 3.306
Veracyte, Inc. 0.3106
Inogen, Inc. -0.1424